Milan, Nov 12. (Adnkronos Health) – Every day our lungs, silently and automatically, work for us. But how much space do we truly reserve for their health? This question is the starting point for the symbolic installation promoted by Msd Italia on the occasion of World Pneumonia Day, the global day dedicated to the knowledge and awareness of pneumonia, scheduled every November 12. The initiative, developed by the biopharmaceutical multinational together with the creative agency Bbdo Italy, aims to bring lung health back to the center of public debate and raise awareness about the prevention of potentially dangerous respiratory infections, such as those caused by pneumococcus, preventable with vaccination.
To give visibility to a still little-discussed topic, Msd explains in a note, the project transforms one of the most typical elements of Italian cities into a powerful symbol: narrow alleys. And so, in Liguria, the region with the highest average age in Italy, and in Marche, among the 10 longest-lived, an installation appeared consisting of two air-filled lungs placed in a particularly cramped space and seemingly crushed by the surrounding walls: in Genoa in Vico Morchi and in Macerata in Traversa Armaroli. An unexpected, immediate, and highly evocative image, the company describes: precisely the narrowness of the space makes the campaign’s message evident and communicates the importance of giving more space to this fundamental organ for a healthy life. The initiative is part of the ‘You can’t wait any longer’ campaign, which aims to shine a spotlight on the prevention of pneumococcal diseases, including pneumonia, through vaccination. With this innovative activity, approved by the Ministry of Health, Msd raises attention to a public health issue little present in daily conversation, through an urban experience capable of surprising and intriguing. An ordinary place becomes an extraordinary opportunity to inform, raise awareness, and remind passers-by to make space for prevention and anti-pneumococcal vaccination.
“Our commitment to lung health, in preventing pneumococcal pneumonia, has deep roots: since 1970, Msd has been a pioneer in scientific research against this dangerous bacterium, guiding the evolution of vaccines capable of protecting entire generations,” recalls Nicoletta Luppi, president and CEO of Msd Italia. “Today,” she continues, “we celebrate this extraordinary legacy with increasingly innovative and personalized preventive solutions, designed to protect respiratory health at every stage of life, from newborns to the elderly. But innovation is not enough; it is important that people can be informed. With this out-of-the-box activation, we want to make noise and break the silence on a crucial issue, stimulating a dialogue with doctors regarding pneumonia prevention and anti-pneumococcal vaccination.”
“Pneumonia is a complex and potentially serious pathology that can severely compromise respiratory function and quality of life,” states Giancarlo Icardi, former Professor of Hygiene at the University of Genoa. “The most vulnerable subjects are newborns, adults suffering from chronic diseases or risk factors, and those over 65. For all these categories, anti-pneumococcal vaccination represents the most effective and safest prevention tool, and it is important to remember that the National Vaccination Prevention Plan guarantees its free availability, making protection an accessible right for everyone to safeguard their respiratory health.”
According to Istisan Report 26 – reports Msd Italia – in our country, in 2023, pneumonia deaths totaled 15,450, and almost all of these, 96% (14,894), are attributable to men and women over 65. Furthermore, between 2010 and 2019, pneumonia caused almost 2.5 million hospitalizations in Italy, confirming itself as one of the main threats to public health. Epidemiological data paint a clear picture: adults are primarily affected, representing almost 90% of cases (over 2.2 million hospitalizations), with a slight prevalence among men compared to women. The impact of the disease grows exponentially with age: the most vulnerable group is the ‘super-elderly’ between 75 and 86 years old, who alone account for 30% of all hospitalizations, while young adults (18-45 years old) record the lowest share (only 6%). Moreover, since 2014, there has been a progressive increase in hospitalizations with pneumonia as the primary diagnosis. Finally, it is important to emphasize that pneumococcus remains the number one enemy, solely responsible for about 20% of cases, followed by other bacterial infections (17%), Mycoplasma (13%), and Pseudomonas (12%).